Search

everythinglearnresearchcommunity

for

Search:↓

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

A global, inclusive approach is needed to address COVID-19 and protect vulnerable groups.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

A new method can quickly and accurately detect illegal chemicals in hair loss products.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Bilobetin may help reduce acne by decreasing sebum production.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Collider bias can distort our understanding of COVID-19 risk and severity.

Women are more likely to have long-term post-COVID symptoms than men.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Collider bias can mislead our understanding of COVID-19 risk and severity.

Age, health conditions, race, and gender affect COVID-19 risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Women with PCOS may be at higher risk for severe COVID-19.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Higher androgen levels might make COVID-19 worse, especially in men.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.